Growth Metrics

Insulet (PODD) Cash from Operations (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -37.92%
Dec 31, 2025 45.82%
Sep 30, 2025 -36.03%
Jun 30, 2025 207.99%
Mar 31, 2025 -56.75%
Dec 31, 2024 36.20%
Sep 30, 2024 24.77%
Jun 30, 2024 -0.91%
Mar 31, 2024 93.81%
Dec 31, 2023 -19.29%
Sep 30, 2023 27.27%
Jun 30, 2023 8,700.00%
Mar 31, 2023 -99.01%
Dec 31, 2022 -10.58%
Sep 30, 2022 124.11%
Jun 30, 2022 284.67%
Mar 31, 2022 46.27%
Dec 31, 2021 1.16%
Sep 30, 2021 -240.98%
Jun 30, 2021 152.14%
Mar 31, 2021 -306.47%
Dec 31, 2020 -61.54%
Sep 30, 2020 67.42%
Jun 30, 2020 833.33%
Mar 31, 2020 -107.68%
Dec 31, 2019 50.80%
Sep 30, 2019 123.74%
Jun 30, 2019 113.85%
Mar 31, 2019 -78.65%
Dec 31, 2018 91.99%
Sep 30, 2018 358.69%
Jun 30, 2018 -43.67%
Mar 31, 2018 -119.49%
Dec 31, 2017 -5.95%
Sep 30, 2017 29.58%
Jun 30, 2017 182.27%
Mar 31, 2017 -208.79%
Dec 31, 2016 649.72%
Sep 30, 2016 -27.28%
Jun 30, 2016 135.00%
Mar 31, 2016 43.44%
Dec 31, 2015 -312.61%
Sep 30, 2015 1,014.14%
Jun 30, 2015 122.51%
Mar 31, 2015 -175.71%
Dec 31, 2014 -4.46%
Sep 30, 2014 849.21%
Jun 30, 2014 149.95%
Mar 31, 2014 71.09%
Dec 31, 2013 -195.24%
Sep 30, 2013 -15.51%
Jun 30, 2013 464.33%
Mar 31, 2013 78.54%
Dec 31, 2012 -62.16%
Sep 30, 2012 68.97%
Jun 30, 2012 -24.83%
Mar 31, 2012 -16.11%
Dec 31, 2011 -817.22%
Sep 30, 2011 90.79%
Jun 30, 2011 -15.46%
Mar 31, 2011 -2.12%
Dec 31, 2010 40.12%